Osvyrti
Denosumab-desu · Accord BioPharma Inc.
PRESCRIPTION ONLY (USA)Osvyrti ingredients
| Active ingredient | Strength |
|---|---|
| Denosumab | 60 mg/mL |
What Osvyrti is used for
Osvyrti is a specialist medicine (rank ligand inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Osvyrti
- Generic name
- Denosumab-desu
- Made by
- Accord BioPharma Inc.
- Forms
- Injection
- Given
- Subcutaneous
- Drug class
- RANK Ligand Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761424
- On the US market since
- 2026
Official information
- Osvyrti prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Denosumab-desu)
In India
- Denosumab: 11 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Osvyrti?
Osvyrti (Denosumab-desu) is a specialist medicine made by Accord BioPharma Inc., approved by the US FDA.
What are the ingredients of Osvyrti?
Osvyrti contains Denosumab (60 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA